---
figid: PMC4977549__srep31375-f1
figtitle: ‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and
  Systemic Lupus Erythematosus patients’
organisms:
- NA
pmcid: PMC4977549
filename: srep31375-f1.jpg
figlink: /pmc/articles/PMC4977549/figure/f1/
number: F1
caption: By using the tool microRNA Target Filter of QIAGEN’s Ingenuity Pathway Analysis
  (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity), the software generated a
  network including the selected miRNAs and their mRNA targets, filtered by connective
  tissue disorders. Only targets experimentally observed and predicted with high confidence
  are shown and related by direct interactions with their specific miRNA regulators.
papertitle: ‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and
  Systemic Lupus Erythematosus patients’.
reftext: C. Pérez-Sánchez, et al. Sci Rep. 2016;6:31375.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8146986
figid_alias: PMC4977549__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4977549__F1
ndex: 9dde939d-de9e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4977549__srep31375-f1.html
  '@type': Dataset
  description: By using the tool microRNA Target Filter of QIAGEN’s Ingenuity Pathway
    Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity), the software generated
    a network including the selected miRNAs and their mRNA targets, filtered by connective
    tissue disorders. Only targets experimentally observed and predicted with high
    confidence are shown and related by direct interactions with their specific miRNA
    regulators.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CBL
  - ITPR1
  - ITPR2
  - ITPR3
  - ITGAV
  - F2
  - COL11A2
  - GNAI3
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - GNAQ
  - CCR2
  - ADGRL2
  - CCDC80
  - DCLK2
  - ERVW-5
  - GNAS
  - IRAK2
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - TP53
  - CISH
  - SOCS1
  - STAT3
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAL
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - STAT1
  - SRF
  - ITGB3
  - LONP1
  - RELA
  - LBP
  - EHHADH
  - RPSA
  - NFATC1
  - RAF1
  - RNASE3
  - NFATC3
  - NRAS
  - RHOA
  - OMA1
  - MAPKAPK2
  - MAPK14
  - MYD88
  - TNFRSF18
  - TNFRSF11B
  - BTF3P11
  - KRAS
  - TLR4
  - GSK3B
  - SPP1
  - BCL2
  - CYCS
  - FURIN
  - CHUK
  - BCL10
  - MAPK7
  - ABCC6
  - FOXC1
  - PAK3
  - Cancer
---
